Routine use of livers from deceased donors older than 70: Is it justified?

Transplant International

Volumn 18, Issue 1, 2005, Pages 73-77

  Kim, Dean Y ^a   Cauduro, Silvania P ^b   Bohorquez, Humberto E ^b   Ishitani, Michael B ^b   Nyberg, Scott L ^b   Rosen, Charles B ^b  

^a HENRY FORD HOSPITAL   (United States)

^b Mayo Clinic   (United States)

Author keywords

Hepatitis C; Liver transplantation; Older donor

Indexed keywords

AGE; CONFERENCE PAPER; GRAFT SURVIVAL; HEPATITIS C; HUMAN; LIVER TRANSPLANTATION; ORGAN DONOR; PRIORITY JOURNAL; AGED; ARTICLE; BIOPSY; CADAVER; DONOR; FEMALE; LIVER; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; REPRODUCIBILITY; RESOURCE ALLOCATION; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICS; SURVIVAL;

ACTUARIAL ANALYSIS; AGE FACTORS; AGED; BIOPSY; CADAVER; FEMALE; HUMANS; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RESOURCE ALLOCATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TISSUE DONORS;

EID: 21644485005     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2004.00017.x     Document Type: Conference Paper

References (12)

1. Scientific Registry of Transplant Recipients, 2002. Transplant Statistics: Annual Report. (Cited 19 March 2004). Available at: http://www.ustransplant.org/annual.html.
2. Ploeg RJ, D'Alessandro AM, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation 1993; 55: 807.
3. Washburn WK, Johnson LB, Lewis WD, Jenkins RL. Graft function and outcome of older (≥60 years) donor livers. Transplantation 1996; 61: 1062.
4. Kakar S, Burgart LJ, Charlton MR, Saito Y, Halling K, Thibodeau SN. Origin of adenocarcinoma in a transplanted liver determined by microsatellite analysis. Hum Pathol 2002; 33: 435.
5. Lipshutz GS, Baxter-Lowe L, Nguyen T, Jones KD, Ascher NL, Feng S. Death from donor-transmitted malignancy despite emergency liver retransplantation. Liver Transplant 2003; 9: 1102.
6. Verran DJ, Gurkan A, Dilworth P, et al. Inferior liver allograft survival from cadaveric donors >50 years of age? Clin Transplantation 2001; 15: 106.
7. Romero CJ, Gonzalez EM, Ruiz FC, et al. Use of octogenarian livers safely expands the donor pool. Transplantation 1999; 68: 572.
8. Emre S, Schwartz ME, Altaca G, et al. Safe use of hepatic allografts from donors older than 70 years. Transplantation 1996; 62: 62.
9. Seaberg EC, Belle SH, Beringer KC, Schivins JL, Detre KM. Long-term patient and retransplantation-free survival by selected recipient and donor characteristics: an update from the Pitt-UNOS Liver Transplant Registry. Clin Transplant 1997; 15.
10. de Perrot M, Wigle DA, Pierre AF, et al. Bronchogenic carcinoma after solid organ transplantation. Ann Thorac Surg 2003; 75: 367.
11. Chadburn A, Suciu-Foca N, Cesarman E, Reed E, Michler RE, Knowles DM. Post-transplantation lympho-proliferative disorders arising in solid organ transplant recipients are usually of recipient origin. Am J Pathol 1995; 147: 1862.
12. Velidedeoglu E, Mange KC, Frank A, et al. Factors differentially correlated with the outcome of liver transplantation in HCV+ and HCV- recipients. Transplantation 2004; 77: 1834.